Editorial draft — not for publication yet. Methylphenidate content needs review by a qualified UK healthcare professional before publication. This page is general information and is not advice about an individual prescription.
In short
Ritalin is a UK brand of methylphenidate. UK product records include Ritalin 10 mg immediate-release tablets and Ritalin XL modified-release capsules, used within a clinician-led ADHD treatment programme. They have different release profiles and should not be switched or dose-converted without professional advice. Methylphenidate is prescription-only and a Class B, Schedule 2 controlled drug; it can affect sleep, appetite, pulse, blood pressure and mood.
For the general active-ingredient guide, continue to Methylphenidate medicine guide. This page covers Ritalin-specific product questions.
What is Ritalin (Methylphenidate) used for?
UK product information lists Ritalin 10 mg tablets and Ritalin XL capsules for ADHD as part of a comprehensive treatment programme when supportive measures alone are insufficient. Treatment must be initiated and supervised by a clinician specialised in ADHD. The exact age range, formulation and directions are product-specific.
- Ritalin 10 mg tablets and Ritalin XL capsules are UK methylphenidate products for clinician-led ADHD treatment
- The cited Ritalin product information specifies children aged 6 years and over and adults; clinicians must check the exact product leaflet and licence
- NICE guidance includes methylphenidate among ADHD medicine options, with assessment and monitoring
- Ritalin is not a self-treatment for anxiety, insomnia, weight loss, ordinary tiredness or studying
NICE recommends methylphenidate within ADHD treatment pathways after assessment, while individual product authorisations can specify narrower ages and indications. The Ritalin product information cited here specifies age 6 years and over.
NICE recommends baseline assessment and ongoing monitoring, including pulse, blood pressure and weight; children and young people also need growth monitoring.
NHS guidance advises sticking with the prescribed methylphenidate brand where possible because brands and release profiles can differ.
How does it work?
Methylphenidate is a central nervous system stimulant that affects dopamine and noradrenaline signalling involved in attention and behaviour. Ritalin tablets and Ritalin XL capsules deliver the medicine differently, so their timing and duration are not determined by the ingredient name alone.
How to take Ritalin (Methylphenidate)
- Follow the dispensing label and patient leaflet supplied with your exact Ritalin product.
- Do not switch between immediate-release tablets, Ritalin XL or another brand without advice from your prescriber or pharmacist.
- Do not take extra doses or double a missed dose; ask a pharmacist if the product leaflet does not answer your question.
- Keep this Schedule 2 medicine securely stored and never share it.
- Attend planned reviews and tell the ADHD prescriber about changes in sleep, appetite, mood or other side effects.
Important: Use the instructions on your own prescription or medicine label. Doses and directions can differ between people and products.
Side effects
Possible effects
NHS information lists headache, trouble sleeping and loss of appetite among common methylphenidate side effects. Effects vary by person, brand and formulation.
Seek urgent help
Call 999 for a life-threatening reaction, seizure, collapse, severe allergic reaction or concerning chest pain. Use NHS 111 for urgent advice that is not an emergency.
Warnings and interactions
- Ritalin should be prescribed after appropriate ADHD assessment and supervised by a clinician with relevant expertise.
- Tell the prescriber about cardiovascular conditions, mental-health history, seizures, current medicines and supplements before treatment.
- Do not take methylphenidate with an MAOI or within 14 days after stopping one; ask a pharmacist to check other interactions.
- Alcohol can increase methylphenidate effects and side effects. Ask a clinician or pharmacist about your circumstances.
- Do not drive or operate machinery if your alertness, vision or concentration is impaired.
- Methylphenidate is a controlled medicine. Use only your prescription and do not share it.
Methylphenidate is prescription-only and controlled as a Class B drug and Schedule 2 controlled drug in the UK. These ingredient-level rules do not mean Ritalin is suitable for an individual without assessment and prescription.
Ritalin tablets and Ritalin XL are different products
UK product information includes Ritalin 10 mg immediate-release tablets and Ritalin XL modified-release capsules. Both contain methylphenidate hydrochloride, but the XL capsule releases the medicine in phases. Check the full name and formulation on your prescription.
Do not switch brands or formulations using a dose-conversion chart. NHS guidance and NHS Specialist Pharmacy Service note that modified-release methylphenidate products may release medicine differently.
Ritalin for ADHD: clinical assessment and product age range
The UK Ritalin product information describes use as part of a comprehensive ADHD treatment programme in children aged 6 years and over and adults, when supportive measures alone are insufficient. Treatment is initiated and supervised by a clinician specialised in ADHD.
NICE guidance includes methylphenidate among medicine options for ADHD, but a guideline recommendation does not remove product-specific licensing details. The exact product, age, assessment and treatment plan must be checked by the prescriber.
Ritalin is not a medicine for anxiety or insomnia
Methylphenidate is a stimulant used in ADHD care. It is not a self-treatment for anxiety, panic, insomnia, studying, weight loss or ordinary tiredness. Trouble sleeping and reduced appetite can occur as side effects.
If you have attention difficulties, anxiety or sleep problems, speak with a healthcare professional about assessment and appropriate options. Do not use another person’s Ritalin.
Side effects and regular monitoring
Possible effects include headache, trouble sleeping and reduced appetite. NICE recommends monitoring effectiveness and adverse effects, pulse and blood pressure, and weight during ADHD medicine treatment; height and growth are monitored for children and young people.
Contact the prescriber about persistent or concerning effects. Call 999 for a life-threatening emergency such as collapse, seizure, severe allergic reaction or serious chest symptoms.
Frequently asked questions
What is the generic name of Ritalin?
Ritalin contains methylphenidate hydrochloride. Ritalin is the brand name and methylphenidate is the active ingredient.
Is Ritalin prescription-only in the UK?
Yes. Ritalin is prescription-only, and methylphenidate is a Class B, Schedule 2 controlled drug.
What is the difference between Ritalin and Ritalin XL?
Ritalin 10 mg is an immediate-release tablet; Ritalin XL is a modified-release capsule. Their release profiles and instructions differ.
Can Ritalin help with anxiety or sleep?
Ritalin is not a self-treatment for anxiety or insomnia. It is a prescription ADHD medicine, and sleep problems can occur as a side effect.
Can I switch from Ritalin to Concerta?
Do not switch or convert products yourself. A prescriber or pharmacist should check the exact formulation, directions and follow-up.
Explore the detailed ritalin (methylphenidate) guides
Each guide answers a different practical question. Advice is specific to methylphenidate and should be checked against your own product leaflet and prescription.
- What is Ritalin? Methylphenidate brand and UK products explained
- Is Ritalin prescription-only in the UK? Controlled status explained
- Ritalin for ADHD: UK product information and clinical guidance
- Ritalin 10 mg vs Ritalin XL: immediate and modified release
- How to take Ritalin safely: tablets, Ritalin XL and prescriptions
- Ritalin side effects and ADHD treatment monitoring
- Ritalin interactions: alcohol, antidepressants and driving
- Ritalin vs Concerta: methylphenidate brands and release differences
Sources and review
This draft was checked against the sources below on 3 October 2026. It still requires review by a qualified UK healthcare professional review before publication.
- electronic Medicines Compendium: Ritalin 10 mg tablets: UK Summary of Product Characteristics
- electronic Medicines Compendium: Ritalin 10 mg tablets: patient information leaflet
- electronic Medicines Compendium: Ritalin XL modified-release capsules: UK Summary of Product Characteristics
- electronic Medicines Compendium: Ritalin XL: patient information leaflet
- NHS: About methylphenidate for adults
- NHS: About methylphenidate for children
- NHS: How and when to take methylphenidate for adults
- NHS: Methylphenidate side effects and urgent advice
- NHS: Methylphenidate interactions with medicines and supplements
- NHS: Common questions about methylphenidate, driving and alcohol
- NICE: ADHD diagnosis, treatment and monitoring recommendations
- NHS Specialist Pharmacy Service: Prescribing and switching between modified-release methylphenidate products
- Home Office / GOV.UK: Controlled drugs list and schedules
Editorial status: Clinical review required before publication.